Jan H. - Consultant

The Hague, Netherlands

Experience

Apr 2023 - Present

2 years 5 months

Jan 2017 - Mar 2023

6 years 3 months

Designed and held the regulatory dossier for the meniscus prosthesis.
Successfully outsourced manufacturing and clinical studies.
Built the company from scratch and raised €6,3M Venture Capital.
Obtained €5,0M innovation credit from the Dutch Government and €3,6M in grants including the €2,5M EIC accelerator grant.
Achieved ISO 13485 certification and obtained FDA Breakthrough designation in the US for a meniscus replacement device.
Completed enrollment for a second clinical study in December 2022.
ATRO Medical became Medtech Innovator Finalist in 2019 and won the $50k Johnson & Johnson QuickFire Award in 2022.
Left the company with an effective startup team and professional organization for scaling the business.
Built relationships with strategics, consultants, and investment funds for scaling.

Jan 2010 - Dec 2017

8 years

Led preparation for Venture and M&A deals and strategic planning for global product portfolio growth for a €140M business.
Successfully led preparation for acquisitions at Royal DSM (€10B annual turnover).
Delivered hands-on experience in valuation, M&A processes, US business environment, and deal-making.
Resulted in one large US-based acquisition (US$ 360M) and three venture investments.
Supported various Business Units for creating strategic marketing plans for a wide range of medical device products.
Covered cardiovascular, orthopedic devices, ophthalmic, and general surgery areas.
Left DSM with several patent licenses and an initial investment of €600k by DSM Venturing to build the ATRO Medical startup.

Jan 2007 - Dec 2009

3 years

Led the program for a new business area of Personal Nutrition.
Built and executed a business plan for genetic profiling for weight management.
Streamlined and focused the business and project portfolio.
Initiated close collaboration with a spin-out of Philips.
Left due to regulatory uncertainties and financial crisis stopping internal funding.

Jan 2002 - Dec 2007

6 years

Developed new products for the food ingredient market with budget and sales responsibility.
Led the market introduction of a genetically engineered biotech product in the B2B market globally.
Managed sales, R&D, technical support, production, IP, and regulatory approvals globally.
Launched the product worldwide within six months.
Major success in China, Eastern Europe, and South America.
Fully realized a high-margin business plan within five years after launch.
Moved to the DSM business group Innovation.

Jan 1997 - Dec 2002

6 years

Managed projects for developing new or improved food ingredient production processes.
Developed an alternative process for vitamin B12 production.
Created new products based on a protein-digesting enzyme.
Commercialized biotechnology molecules for applications in cosmetics, crop protection, beer, and dairy industries.
Promoted internally to Business Manager to transform ideas into commercially viable products.

Jan 1993 - Dec 1997

5 years

Managed biotechnology-driven product portfolios for Unilever's food and cosmetics business groups.
Conducted fundamental research and developed enzymes, yeast extracts, flavoring, and malodor treatment products.
One product reached the cosmetic market after departure.
Left Unilever as biotechnology was no longer a core business, and related groups were divested.

Jan 1993 - Dec 1993

1 year